Mark Timney

Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane
Endpoints
Mon, 11/8/21 - 10:53 am
Mark Timney
SPAC
Blade Therapeutics
Purdue Pharma
Biotech Acquisition Company
Ex-Purdue Pharma chief Mark Timney, named in dozens of opioid lawsuits, nabs another biotech CEO gig
Endpoints
Mon, 05/10/21 - 08:14 pm
Mark Timney
Purdue Pharma
opioids
opioid crisis
Attralus
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Endpoints
Mon, 11/25/19 - 09:47 pm
Mark Timney
Purdue Pharma
Novartis
Medicines Company
M&A